Table 5.
Overview of top AI-oriented pharmaceutical and biotechnology Start-ups across the globe with major applications in the drug discovery pipeline.
| Sr. No. | Company | Country | Year | Major Applications | Revenue/Year | Link |
|---|---|---|---|---|---|---|
| 1 | Atomwise | USA | 2012 | Machine learning based discovery of small molecule oriented medicines | 17.1M USD | https://www.atomwise.com/ |
| 2 | Verge Genomics | USA | 2015 | Drug design for neurodegenrative disease | 2.78M USD | https://www.vergegenomics.com/ |
| 3 | Biovista | USA | 1996 | Drug re-positioning and de-risking, personalized medicine | 4M USD | https://www.biovista.com/ |
| 4 | Aria Pharmaceuticals | USA | 2015 | Small molecule design | 5M USD | https://ariapharmaceuticals.com/ |
| 5 | PathAI | USA | 2016 | Digital pathology analysis for drug development | 255M USD | https://www.pathai.com/ |
| 6 | Recursion Pharmaceuticals | USA | 2013 | Clinical stage drug development | 2.5M USD | https://www.recursion.com/ |
| 7 | Valohealth | USA | 2007 | An integrated system for end-to-end drug development | 19.4M USD | https://www.valohealth.com// |
| 8 | Catalia Health | USA | 2014 | AI-based platform for remote heath care management | 5.9M USD | http://www.cataliahealth.com/ |
| 9 | Verantos | USA | A real world evidence (RWE) company for clinical, regulatory and reimbursement claims. | https://verantos.com/ | ||
| 10 | Insitro | USA | 2018 | Predictive models for drug development | 20.6M USD | https://insitro.com/ |
| 11 | Trials.ai | USA | 2016 | Intelligent AI clinical design | 1.2M USD | https://www.trials.ai/about-us/ |
| 12 | ReviveMed | USA | 2016 | AI-driven drug design for metabolomic diseases | 0.26M USD | https://www.revivemed.io/ |
| 13 | OneThree Biotech | USA | 2018 | AI-driven drug discovery platform with multiple clinical validations | 3.5M USD | https://onethree.bio/ |
| 14 | BERG Health | USA | 2009 | Clinical-stage AI-driven biotechnology company | 17.9M USD | https://www.berghealth.com/ |
| 15 | BenevolentAI | UK | 2013 | Explore inter-connected disease network using data to design effective treatment strategies and drug development. | 45.4M USD | https://www.benevolent.com/ |
| 16 | Nuleome Therapeutics | UK | 2019 | Decoding dark matter of human genome for new ways of disease treatment | 6.3M USD | https://nucleome.com/ |
| 17 | BioSymetrics | Canada | 2015 | Phenomics-driven approach for drug discovery | 2.6M USD | https://www.biosymetrics.com/ |
| 18 | Deep Genomics | Canada | 2014 | AI-based platform for complexities in RNA biology for drug development | 9.5M USD | https://www.deepgenomics.com/ |
| 19 | Insilico Medicine | Hong Kong | 2014 | AI-assisted identification of drugs | 10.9M USD | https://insilico.com/ |
| 20 | iCarbonX | China | 2015 | Multi-omics technologies for innovative biomarkers discovery | 5M USD | https://www.icarbonx.com/en/ |